MDx-Chex™ for BCID2 by Streck Inc.
Manufacturer Streck Inc. | Available Worldwide
MDx-Chex for BCID2 is a first-of-its-kind quality control designed to meet the standards for verifying the performance of the BioFire® BCID2 Panel Assay for sepsis. Provided in a comprehensive and easy-to-use format, MDx-Chex for BCID2 evaluates the entire analytical process of the assay, including cell lysis, DNA extraction, purification and removal of PCR inhibitors, as well as qPCR amplification, detection and analysis.
MDx-Chex™ for BCID2
MDx-Chex for BCID2 is a patient-like full process control designed to validate the entire analytical process of the BioFire BCID2 Panel assay. The control kit contains 43 bacteria, yeasts, and antimicrobial resistance gene targets packaged in two separate vials, one for Gram (-) bacteria and one for Gram (+) bacteria and yeasts, covering targets commonly tested for in molecular sepsis tests. The microorganisms are intact, inactivated, and suspended in a matrix of stabilized red blood cells, white blood cells, and blood culture media components, which is designed to challenge the lysis and purification processes just like a patient sample.
Product Overview
MDx-Chex™ for BCID2
Manufacturer Streck Inc. | Available Worldwide
Be the first to review this product
